Physician profile
Mai Tsukikawa
NPI 1093249682
$4,435.14
in general payments reported to CMS, 2019-2025
13 companies · $3,141 in 2025
The $3,141 reported for 2025 was more than what 88% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $68.42 · 2023: $141 · 2024: $917 · 2025: $3,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,360 · Long Term Medical Supply Or Device Loan: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,360.46 |
| Long Term Medical Supply Or Device Loan | $838.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,691.11 | 2023-2025 | Unity, Rocklatan, Clareon |
| Sight Sciences, INC. | $1,219.98 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Dompe US, INC. | $280.81 | 2024-2025 | Oxervate |
| Regeneron Healthcare Solutions, INC. | $225.26 | 2024-2025 | Eylea Hd |
| Glaukos Corporation | $194.51 | 2025 | Idosetr |
| Genentech, INC. | $135.43 | 2024 | Vabysmo |
| Amgen INC. | $135.00 | 2025 | |
| Ani Pharmaceuticals, INC. | $124.99 | 2025 | Purified Cortrophin Gel |
| Rxsight INC | $120.75 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Mallinckrodt Hospital Products INC. | $114.97 | 2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $106.61 | 2021 | |
| Biotissue Holdings INC. | $50.00 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $35.72 | 2025 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mai Tsukikawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.